Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation

被引:53
作者
Dobson, Lynne [1 ]
Conway, Catherine
Hanley, Alan
Johnson, Alex
Costello, Sean
O'Grady, Anthony [2 ,3 ]
Connolly, Yvonne [4 ]
Magee, Hilary [4 ]
O'Shea, Daniel [4 ]
Jeffers, Michael [4 ]
Kay, Elaine [2 ,3 ]
机构
[1] SlidePath Ltd, Swift Sq, Dublin 9, Ireland
[2] Beaumont Hosp, Dept Histopathol, Dublin 9, Ireland
[3] Royal Coll Surgeons Ireland, Dublin 2, Ireland
[4] Adelaide & Meath Incorporating Natl Childrens Hos, Dept Histopathol, Dublin, Ireland
关键词
fluorescence in situ hybridization; HER-2; image analysis; immunohistochemistry; virtual slides; IN-SITU HYBRIDIZATION; AUTOMATED QUANTITATIVE-ANALYSIS; METASTATIC BREAST-CANCER; OF-CLINICAL-ONCOLOGY; AMERICAN-SOCIETY; EXPRESSION; AMPLIFICATION; ACCURACY; ASSAY; REPRODUCIBILITY;
D O I
10.1111/j.1365-2559.2010.03577.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Accurate determination of HER-2 status is critical to identify patients for whom trastuzumab treatment will be of benefit. Although the recommended primary method of evaluation is immunohistochemistry, numerous reports of variability in interpretation have raised uncertainty about the reliability of results. Recent guidelines have suggested that image analysis could be an effective tool for achieving consistent interpretation, and this study aimed to assess whether this technology has potential as a diagnostic support tool. Methods and results: Across a cohort of 275 cases, image analysis could accurately classify HER-2 status, with 91% agreement between computer-aided classification and the pathology review. Assessment of the continuity of membranous immunoreactivity in addition to intensity of reactivity was critical to distinguish between negative and equivocal cases and enabled image analysis to report a lower referral rate of cases for confirmatory fluorescence in situ hybridization (FISH) testing. An excellent concordance rate of 95% was observed between FISH and the automated review across 136 informative cases. Conclusions: This study has validated that image analysis can robustly and accurately evaluate HER-2 status in immunohistochemically stained tissue. Based on these findings, image analysis has great potential as a diagnostic support tool for pathologists and biomedical scientists, and may significantly improve the standardization of HER-2 testing by providing a quantitative reference method for interpretation.
引用
收藏
页码:27 / 38
页数:12
相关论文
共 40 条
[1]  
Camp RL, 2003, CANCER RES, V63, P1445
[2]   HER-2 status in breast cancer - Correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system [J].
Ciampa, Armando ;
Xu, Bo ;
Ayata, Gamze ;
Baiyee, Daniel ;
Wallace, Jan ;
Wertheimer, Michael ;
Edmiston, Kathryn ;
Khan, Ashraf .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2006, 14 (02) :132-137
[3]   Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs [J].
Conway, Catherine ;
Dobson, Lynne ;
O'Grady, Anthony ;
Kay, Elaine ;
Costello, Sean ;
O'Shea, Daniel .
HISTOCHEMISTRY AND CELL BIOLOGY, 2008, 130 (03) :447-463
[4]  
Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026
[5]   A quality assurance exercise to evaluate the accuracy and reproducibility of chromogenic in situ hybridisation for HER2 analysis in breast cancer [J].
Di Palma, S. ;
Collins, N. ;
Bilous, M. ;
Sapino, A. ;
Mottolese, M. ;
Kapranos, N. ;
Schmitt, F. ;
Isola, J. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (06) :757-760
[6]   Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists [J].
Dietel, M. ;
Ellis, I. O. ;
Hoefler, H. ;
Kreipe, H. ;
Moch, H. ;
Dankof, A. ;
Koelble, K. ;
Kristiansen, G. .
VIRCHOWS ARCHIV, 2007, 451 (01) :19-25
[7]   Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma [J].
DiVito, KA ;
Berger, AJ ;
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL ;
Kluger, HM .
CANCER RESEARCH, 2004, 64 (23) :8773-8777
[8]   Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome [J].
Dolled-Filhart, Marisa ;
McCabe, Anthony ;
Giltnane, Jennifer ;
Cregger, Melissa ;
Camp, Robert L. ;
Rimm, David L. .
CANCER RESEARCH, 2006, 66 (10) :5487-5494
[9]   Standardization of HER2 testing:: results of an international proficiency-testing ring study [J].
Dowsett, Mitch ;
Hanna, Wedad M. ;
Kockx, Mark ;
Penault-Llorca, Frederique ;
Rueschoff, Josef ;
Gutjahr, Thorsten ;
Habben, Kai ;
van de Vijver, Marc J. .
MODERN PATHOLOGY, 2007, 20 (05) :584-591
[10]   Tissue microarray technology in breast cancer HER2 diagnostics [J].
Egervari, Kristof ;
Szollosi, Zoltan ;
Nemes, Zoltan .
PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (03) :169-177